Revere Kinkel

Title(s)Professor Of Clinical, Neurosciences
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression. Brain Commun. 2021; 3(3):fcab134. Treaba CA, Conti A, Klawiter EC, Barletta VT, Herranz E, Mehndiratta A, Russo AW, Sloane JA, Kinkel RP, Toschi N, Mainero C. PMID: 34704024; PMCID: PMC8361394.
      View in: PubMed   Mentions: 4  
    2. Quantification of smooth pursuit dysfunction in multiple sclerosis. Mult Scler Relat Disord. 2021 Sep; 54:103073. Rempe T, Dastgheyb N, Miner A, Palomino M, Kinkel R, Liston D, Graves JS. PMID: 34214878.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI. J Neurol. 2021 Jul; 268(7):2473-2481. Treaba CA, Herranz E, Barletta VT, Mehndiratta A, Ouellette R, Sloane JA, Klawiter EC, Kinkel RP, Mainero C. PMID: 33523256.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    4. Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis Episode. JAMA Netw Open. 2020 11 02; 3(11):e2016278. Plavina T, Singh CM, Sangurdekar D, de Moor C, Engle B, Gafson A, Goyal J, Fisher E, Szak S, Kinkel RP, Sandrock AW, Su R, Kieseier BC, Rudick RA. PMID: 33151313; PMCID: PMC7645699.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    5. MOG-IgG1 and co-existence of neuronal autoantibodies. Mult Scler. 2021 07; 27(8):1175-1186. Kunchok A, Flanagan EP, Krecke KN, Chen JJ, Caceres JA, Dominick J, Ferguson I, Kinkel R, Probasco JC, Ruvalcaba M, Santoro JD, Sieloff K, Timothy J, Weinshenker BG, McKeon A, Pittock SJ. PMID: 32907470; PMCID: PMC8454216.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    6. Characterization of thalamic lesions and their correlates in multiple sclerosis by ultra-high-field MRI. Mult Scler. 2021 04; 27(5):674-683. Mehndiratta A, Treaba CA, Barletta V, Herranz E, Ouellette R, Sloane JA, Klawiter EC, Kinkel RP, Mainero C. PMID: 32584159; PMCID: PMC7759586.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    7. Outcomes and Cost-Effectiveness of Autologous Hematopoietic Cell Transplant for Multiple Sclerosis. Curr Treat Options Neurol. 2019 Oct 17; 21(10):53. Dunn-Pirio AM, Heyman BM, Kaufman DS, Kinkel RP. PMID: 31624926.
      View in: PubMed   Mentions: 4  
    8. Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI. Radiology. 2019 06; 291(3):740-749. Treaba CA, Granberg TE, Sormani MP, Herranz E, Ouellette RA, Louapre C, Sloane JA, Kinkel RP, Mainero C. PMID: 30964421; PMCID: PMC6543899.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    9. Guided Imagery Improves Mood, Fatigue, and Quality of Life in Individuals With Multiple Sclerosis: An Exploratory Efficacy Trial of Healing Light Guided Imagery. J Evid Based Integr Med. 2018 Jan-Dec; 23:2515690X17748744. Case LK, Jackson P, Kinkel R, Mills PJ. PMID: 29405761; PMCID: PMC5871039.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    10. Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7?T imaging. Mult Scler. 2018 10; 24(11):1433-1444. Louapre C, Govindarajan ST, Giann? C, Madigan N, Sloane JA, Treaba CA, Herranz E, Kinkel RP, Mainero C. PMID: 28803512.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    11. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7�T MRI. Neuroimage Clin. 2016; 12:879-886. Louapre C, Govindarajan ST, Giann? C, Madigan N, Nielsen AS, Sloane JA, Kinkel RP, Mainero C. PMID: 27872810; PMCID: PMC5107649.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    12. Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol. 2016 Nov; 80(5):776-790. Herranz E, Giann? C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C. PMID: 27686563; PMCID: PMC5115951.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    13. Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T. Neurology. 2015 Nov 10; 85(19):1702-9. Louapre C, Govindarajan ST, Giann? C, Langkammer C, Sloane JA, Kinkel RP, Mainero C. PMID: 26468411; PMCID: PMC4653110.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    14. Is the Relationship between Cortical and White Matter Pathologic Changes in Multiple Sclerosis Spatially Specific? A Multimodal 7-T and 3-T MR Imaging Study with Surface and Tract-based Analysis. Radiology. 2016 Feb; 278(2):524-35. Louapre C, Govindarajan ST, Giann? C, Cohen-Adad J, Gregory MD, Nielsen AS, Madigan N, Sloane JA, Kinkel RP, Mainero C. PMID: 26334679; PMCID: PMC4734161.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    15. No Evidence of Disease Activity in Multiple Sclerosis. JAMA Neurol. 2015 Jul; 72(7):835-6. Sloane JA, Mainero C, Kinkel RP. PMID: 26167901.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain. 2015 Apr; 138(Pt 4):932-45. Mainero C, Louapre C, Govindarajan ST, Giann? C, Nielsen AS, Cohen-Adad J, Sloane J, Kinkel RP. PMID: 25681411; PMCID: PMC4677339.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    17. Disease-related determinants of quality of life 10 years after clinically isolated syndrome. Int J MS Care. 2015 Jan-Feb; 17(1):26-34. Kinkel RP, Laforet G, You X. PMID: 25741224; PMCID: PMC4338640.
      View in: PubMed   Mentions: 3  
    18. Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis. J Cereb Blood Flow Metab. 2015 Jan; 35(1):131-9. Fan AP, Govindarajan ST, Kinkel RP, Madigan NK, Nielsen AS, Benner T, Tinelli E, Rosen BR, Adalsteinsson E, Mainero C. PMID: 25352043; PMCID: PMC4294406.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    19. Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome. Mult Scler Relat Disord. 2014 Nov; 3(6):712-9. Kinkel RP, Simon JH, O'Connor P, Hyde R, Pace A. PMID: 25891550.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34. Chalkias S, Dang X, Bord E, Stein MC, Kinkel RP, Sloane JA, Donnelly M, Ionete C, Houtchens MK, Buckle GJ, Batson S, Koralnik IJ. PMID: 24687904; PMCID: PMC4425205.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    21. Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology. 2013 Aug 13; 81(7):641-9. Nielsen AS, Kinkel RP, Madigan N, Tinelli E, Benner T, Mainero C. PMID: 23864311; PMCID: PMC3775688.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    22. Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2. J Magn Reson Imaging. 2012 Mar; 35(3):537-42. Nielsen AS, Kinkel RP, Tinelli E, Benner T, Cohen-Adad J, Mainero C. PMID: 22045554; PMCID: PMC4198329.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    23. Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance. Arch Neurol. 2012 Feb; 69(2):183-90. Kinkel RP, Dontchev M, Kollman C, Skaramagas TT, O'Connor PW, Simon JH, Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance. PMID: 21987393.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansPHPublic Health
    24. Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis. Mult Scler. 2012 Mar; 18(3):377-8. Nielsen AS, Miravalle A, Langer-Gould A, Cooper J, Edwards KR, Kinkel RP. PMID: 21828201.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    25. Internet portal use in an academic multiple sclerosis center. J Am Med Inform Assoc. 2012 Jan-Feb; 19(1):128-33. Nielsen AS, Halamka JD, Kinkel RP. PMID: 21571744; PMCID: PMC3240754.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    26. Experiences acquiring and using mobility aids among working-age persons with multiple sclerosis living in communities in the United States. Am J Phys Med Rehabil. 2010 Dec; 89(12):1010-23. Iezzoni LI, Rao SR, Kinkel RP. PMID: 20881588.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol. 2011 Feb; 68(2):186-91. Miravalle A, Jensen R, Kinkel RP. PMID: 20937940.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansPHPublic Health
    28. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009 Sep 10; 361(11):1067-74. Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ. PMID: 19741227; PMCID: PMC3077718.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCellsCTClinical Trials
    29. Patterns of mobility aid use among working-age persons with multiple sclerosis living in the community in the United States. Disabil Health J. 2009 Apr; 2(2):67-76. Iezzoni LI, Rao SR, Kinkel RP. PMID: 21122745.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    30. Health-related quality of life assessment in multiple sclerosis. Rev Neurol Dis. 2008; 5(2):56-64. Miller DM, Kinkel RP. PMID: 18660737.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Acute paraplegia with vanishing white matter lesions. Rev Neurol Dis. 2008; 5(3):159-60; discussion 164-6. Jensen RM, Kinkel RP. PMID: 18838956.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Interferon-beta1a: a once-weekly immunomodulatory treatment for patients with multiple sclerosis. Expert Rev Clin Immunol. 2006 Sep; 2(5):691-704. Kinkel RP. PMID: 20477625.
      View in: PubMed   Mentions: 1     Fields:    
    33. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology. 2006 Mar 14; 66(5):678-84. Kinkel RP, Kollman C, O'Connor P, Murray TJ, Simon J, Arnold D, Bakshi R, Weinstock-Gutman B, Brod S, Cooper J, Duquette P, Eggenberger E, Felton W, Fox R, Freedman M, Galetta S, Goodman A, Guarnaccia J, Hashimoto S, Horowitz S, Javerbaum J, Kasper L, Kaufman M, Kerson L, Mass M, Rammohan K, Reiss M, Rolak L, Rose J, Scott T, Selhorst J, Shin R, Smith C, Stuart W, Thurston S, Wall M, CHAMPIONS Study Group. PMID: 16436649.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    34. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. Ann Neurol. 2002 Apr; 51(4):481-90. Beck RW, Chandler DL, Cole SR, Simon JH, Jacobs LD, Kinkel RP, Selhorst JB, Rose JW, Cooper JA, Rice G, Murray TJ, Sandrock AW. PMID: 11921054.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Revere's Networks
    Concepts (133)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version pre_new_search-4-g7119b7be on PROFILES-PWEB04.

    Copyright © The Regents of the University of California